Sangamo Biosciences reported $654.31M in Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Alnylam Pharmaceuticals ALNY:US $ 3433.54M 209.76M
Amgen AMGN:US $ 59196M 1969M
Avrobio Inc AVRO:US $ 175.34M 28.49M
Bayer BAYN:GR € 125782M 5541M
Biocryst Pharmaceuticals BCRX:US $ 527.72M 60.43M
Biogen BIIB:US $ 23614.4M 262.9M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Gilead Sciences GILD:US $ 63080M 4872M
GlaxoSmithKline GSK:LN 89689M 10586M
Intercept Pharmaceuticals ICPT:US $ 503.36M 23.67M
IONIS PHARMACEUT IONS:US $ 2519.09M 92.6M
Johnson & Johnson JNJ:US $ 178355M 3663M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Merk MRK:US $ 106668M 974M
Novartis NOVN:VX SF 125218M 6577M
Omeros OMER:US $ 369.26M 50M
Regulus Therapeutics RGLS:US $ 60.98M 7.47M
Sangamo Biosciences SGMO:US $ 654.31M 67.61M
Sarepta Therapeutics SRPT:US $ 3056.15M 91.82M
Ultragenyx Pharmaceutical RARE:US $ 1384.03M 138.37M
Vertex Pharmaceuticals VRTX:US $ 14256.1M 823.6M
Ziopharm Oncology ZIOP:US $ 84.99M 9.87M